Paper - WANFANG MED ONLINE

You Position: Home > Paper

Diagnosis of subsegmental pulmonary embolism and andadvance of anticoagulant therapy

( views:111, downloads:29 )

Author:: No author available

Journal Title:: International Journal of Respiration

Issue:: 3

DOI:: 10.3760/cma.j.cn131368-20211201-00889

Key Word:: 肺栓塞;诊断;治疗;Pulmonary embolism;Diagnosis;Treatment

Abstract： Pulmonary embolism presents the third most common cause of death in cardiovascular diseases.Recently, the rapid development of imaging technology has gradually increased the detection rate of subsegmental pulmonary embolism.But in fact, due to the lack of specific data including clinical manifestations, potential related complications and long-term follow-up, it remain controversial that respect to clinical significance of subsegmental pulmonary embolism and benefit of anticoagulant therapy.This article reviews the evaluation, diagnosis and treatment of subsegment pulmonary embolism, aiming to provide reference and guidance for clinical treatment of subsegmental pulmonary embolism, broaden cognize for physician who was on the front lines (department of clinic and imaging) on venous thromboembolism.

Reference

[1]Hiraide, Makoto,Shiga, Taro,Minowa, Yuichi,etc.Identification of risk factors for venous thromboembolism and evaluation of Khorana venous thromboembolism risk assessment in Japanese lung cancer patients[J].2020,75(1/2).
[2]Ucar, Elif Yilmazel,Gorguner, Ali Metin,Yalcin, Aslihan,etc.Predictive value of serum Hs-CRP levels for outcomes of pulmonary embolism[J].2016,10(2).
[3]Prakash,Saha,Alberto,Smith.TNF-α (Tumor Necrosis Factor-α).[J].2018,38(11).
[4]Xue,Yan,Guowei,Li.Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer.[J].2020,40(3).
[5]GuptaRajesh,AmmariZaid,DasaOsama,etc.Long-term mortality after massive, submassive, and low-risk pulmonary embolism[J].2020,25(2).
[6]Janette, Bester,Etheresia, Pretorius.Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity.[J].2016.
[7]Luther, Natascha,Shahneh, Fatemeh,Braehler, Melanie,etc.Innate Effector-Memory T-Cell Activation Regulates Post-Thrombotic Vein Wall Inflammation and Thrombus Resolution[J].2016,119(12).
[8]Wang, Qian,Ma, Junfen,Jiang, Zhiyun,etc.Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute pulmonary embolism: a systematic review and meta-analysis[J].2018,37(1).
[9]Taeyoung Kong,Yoo Seok Park,Hye Sun Lee,etc.Value of the Delta Neutrophil Index for Predicting 28-Day Mortality in Patients With Acute Pulmonary Embolism in the Emergency Department[J].2018,49(6).
[10]Vinita,Yadav,Liguo,Chi,Raymond,Zhao,etc.Ectonucleotidase tri(di)phosphohydrolase-1 (ENTPD-1) disrupts inflammasome/interleukin 1β-driven venous thrombosis.[J].2019,130.
[11]Mizuho,Nosaka,Yuko,Ishida,Akihiko,Kimura,etc.Crucial Involvement of IL-6 in Thrombus Resolution in Mice via Macrophage Recruitment and the Induction of Proteolytic Enzymes.[J].2019,10.
[12]Heo Chan Mi,Kim Tae Jun,Kim Eun Ran,etc.Risk of venous thromboembolism in Asian patients with inflammatory bowel disease: a nationwide cohort study[J].2021,11(1).
[13]Desai, Rishi J.,Gagne, Joshua J.,Lii, Joyce,etc.Comparative risk of incident venous thromboembolism in patients with inflammatory bowel disease initiating tumour necrosis factor-�� inhibitors or nonbiologic agents: a cohort study.[J].2017,189(47).
[14]Bontekoe Emily,Brailovsky Yevgeniy,Hoppensteadt De.Upregulation of Inflammatory Cytokines in Pulmonary Embolism Using Biochip-Array Profiling[J].2021,27.
[15]Golemi, Iva,Adum, Juan Pablo Salazar,Tafur, Alfonso,etc.Venous thromboembolism prophylaxis using the Caprini score[J].2019,65(8).
[16]Janette Bester,Christina Matshailwe,Etheresia Pretorius.Simultaneous presence of hypercoagulation and increased clot lysis time due to IL-1β, IL-6 and IL-8[J].2018,110.
[17]Omar, Elaskalani,Norbaini Binti, Abdol Razak,Pat, Metharom.Neutrophil extracellular traps induce aggregation of washed human platelets independently of extracellular DNA and histones.[J].2018,16(1).
[18]Gupta, Neha,Sahu, Anita,Prabhakar, Amit,etc.Activation of NLRP3 inflammasome complex potentiates venous thrombosis in response to hypoxia[J].2017,114(18).
[19]Del Giudice, Marco,Gangestad, Steven W..Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters[J].2018,70.
[20]Ertem, Ahmet Goktug,Yayla, Cagri,Acar, Burak,etc.Relation between lymphocyte to monocyte ratio and short-term mortality in patients with acute pulmonary embolism[J].2018,12(2).
[21]Mizuho,Nosaka,Yuko,Ishida,Akihiko,Kimura,etc.Contribution of the TNF-α (Tumor Necrosis Factor-α)-TNF-Rp55 (Tumor Necrosis Factor Receptor p55) Axis in the Resolution of Venous Thrombus.[J].2018,38(11).
[22]Yunhong Zhang,Zhen Zhang,Ran Wei,etc.IL (Interleukin)-6 Contributes to Deep Vein Thrombosis and Is Negatively Regulated by miR-338-5p[J].2020,40(2).
[23]Bertin, F. -R.,Rys, R. N.,Mathieu, C.,etc.Natural killer cells induce neutrophil extracellular trap formation in venous thrombosis[J].2019,17(2).
[24]Subhradip,Mukhopadhyay,Tierra A,Johnson,Nadire,Duru,etc.Fibrinolysis and Inflammation in Venous Thrombus Resolution.[J].2019,10.
[25]Gok, Murat,Kurtul, Alparslan.A novel marker for predicting severity of acute pulmonary embolism: systemic immune-inflammation index[J].2021,55(2).
[26]Konstantinides, Stavros V.,Meyer, Guy.The 2019 ESC Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism[J].2019,40(42).
[27]Impellizzieri, Daniela,Ridder, Frederike,Raeber, Miro E.,etc.IL-4 receptor engagement in human neutrophils impairs their migration and extracellular trap formation[J].2019,144(1).
[28]Tainá,Gomes,Carolina B S,Várady,André L,Lourenço,etc.IL-1β Blockade Attenuates Thrombosis in a Neutrophil Extracellular Trap-Dependent Breast Cancer Model.[J].2019,10.